1-10 of 10
Andrea Decensi
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Effect Modifiers of Low-Dose Tamoxifen in a Randomized Trial in Breast Noninvasive Disease

Andrea DeCensi, Matteo Puntoni, Harriet Johansson, Aliana Guerrieri-Gonzaga, Silvia Caviglia, Franca Avino, Laura Cortesi, Antonio Ponti, Maria Grazia Pacquola, Fabio Falcini, Marcella Gulisano, Maria Digennaro, Anna Cariello, Katia Cagossi, Graziella Pinotti, Matteo Lazzeroni, Davide Serrano, Irene Maria Briata, Tania Buttiron Webber, Luca Boni, Bernardo Bonanni
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2021) 27 (13): 3576–3583.
https://doi.org/10.1158/1078-0432.CCR-20-4213
Published: 01 July 2021
View article titled, Effect Modifiers of Low-Dose Tamoxifen in a Randomized Trial in Breast Noninvasive Disease
Open the PDF for Effect Modifiers of Low-Dose Tamoxifen in a Randomized Trial in Breast Noninvasive Disease in another window
Includes: Supplementary data
Journal Articles

Dual Block with Lapatinib and Trastuzumab Versus Single-Agent Trastuzumab Combined with Chemotherapy as Neoadjuvant Treatment of HER2-Positive Breast Cancer: A Meta-analysis of Randomized Trials

Matteo Clavarezza, Matteo Puntoni, Alessandra Gennari, Laura Paleari, Nicoletta Provinciali, Mauro D'Amico, Andrea DeCensi
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (18): 4594–4603.
https://doi.org/10.1158/1078-0432.CCR-15-1881
Published: 15 September 2016
View article titled, Dual Block with Lapatinib and Trastuzumab Versus Single-Agent Trastuzumab Combined with Chemotherapy as Neoadjuvant Treatment of HER2-Positive Breast Cancer: A Meta-analysis of Randomized Trials
Open the PDF for Dual Block with Lapatinib and Trastuzumab Versus Single-Agent Trastuzumab Combined with Chemotherapy as Neoadjuvant Treatment of HER2-Positive Breast Cancer: A Meta-analysis of Randomized Trials in another window
Includes: Supplementary data
Journal Articles

Cancer Prevention and Interception: A New Era for Chemopreventive Approaches

Adriana Albini, Andrea DeCensi, Franco Cavalli, Alberto Costa
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2016) 22 (17): 4322–4327.
https://doi.org/10.1158/1078-0432.CCR-16-0695
Published: 31 August 2016
View article titled, Cancer Prevention and Interception: A New Era for Chemopreventive Approaches
Open the PDF for Cancer Prevention and Interception: A New Era for Chemopreventive Approaches in another window
Journal Articles

Abstract B3: A nested case control study of the polymorphic locus -202 in the promoter region of the IGFBP-3 gene and breast cancer risk

Debora Macis, Patrick Maisonneuve, Hariett Johansson, Valentina Aristarco, Aliana Guerrieri-Gonzaga, Nicole Rotmensz, Barbara Santillo, Giacomo Gucciardo, Giuseppe D'Aiuto, Marco Rosselli del Turco, Alberto Costa, Umberto Veronesi, Andrea Decensi, Bernardo Bonanni
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (7_Supplement): B3.
https://doi.org/10.1158/1078-0432.TCME10-B3
Published: 02 February 2016
View article titled, Abstract B3: A nested case control study of the polymorphic locus -202 in the promoter region of the IGFBP-3 gene and breast cancer risk
Journal Articles

Randomized Biomarker Trial of Anastrozole or Low-Dose Tamoxifen or Their Combination in Subjects with Breast Intraepithelial Neoplasia

Bernardo Bonanni, Davide Serrano, Sara Gandini, Aliana Guerrieri-Gonzaga, Harriet Johansson, Debora Macis, Massimiliano Cazzaniga, Alberto Luini, Enrico Cassano, Sabina Oldani, Ernst A. Lien, Giuseppe Pelosi, Andrea Decensi
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (22): 7053–7060.
https://doi.org/10.1158/1078-0432.CCR-09-1354
Published: 11 November 2009
View article titled, Randomized Biomarker Trial of Anastrozole or Low-Dose Tamoxifen or Their Combination in Subjects with Breast Intraepithelial Neoplasia
Open the PDF for Randomized Biomarker Trial of Anastrozole or Low-Dose Tamoxifen or Their Combination in Subjects with Breast Intraepithelial Neoplasia in another window
Journal Articles

Effect of the Synthetic Retinoid Fenretinide on Circulating Free Prostate-Specific Antigen, Insulin-Like Growth Factor-I, and Insulin-Like Growth Factor Binding Protein-3 Levels in Men with Superficial Bladder Cancer

Davide Serrano, Laura Baglietto, Harriet Johansson, Frederique Mariette, Rosalba Torrisi, Marina Onetto, Michela Paganuzzi, Andrea Decensi
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (5): 2083–2088.
https://doi.org/10.1158/1078-0432.CCR-04-1549
Published: 08 March 2005
View article titled, Effect of the Synthetic Retinoid Fenretinide on Circulating Free Prostate-Specific Antigen, Insulin-Like Growth Factor-I, and Insulin-Like Growth Factor Binding Protein-3 Levels in Men with Superficial Bladder Cancer
Open the PDF for Effect of the Synthetic Retinoid Fenretinide on Circulating Free Prostate-Specific Antigen, Insulin-Like Growth Factor-I, and Insulin-Like Growth Factor Binding Protein-3 Levels in Men with Superficial Bladder Cancer in another window
Journal Articles

A Two-by-Two Factorial Trial Comparing Oral with Transdermal Estrogen Therapy and Fenretinide with Placebo on Breast Cancer Biomarkers

Andrea Decensi, Bernardo Bonanni, Laura Baglietto, Aliana Guerrieri-Gonzaga, Francesca Ramazzotto, Harriet Johansson, Chris Robertson, Irene Marinucci, Frederique Mariette, Maria Teresa Sandri, Cristina Daldoss, Vanda Bianco, Marco Buttarelli, Massimiliano Cazzaniga, Dorella Franchi, Enrico Cassano, Umberto Omodei
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (13): 4389–4397.
https://doi.org/10.1158/1078-0432.CCR-04-0087
Published: 06 July 2004
View article titled, A Two-by-Two Factorial Trial Comparing Oral with Transdermal Estrogen Therapy and Fenretinide with Placebo on Breast Cancer Biomarkers
Open the PDF for A Two-by-Two Factorial Trial Comparing Oral with Transdermal Estrogen Therapy and Fenretinide with Placebo on Breast Cancer Biomarkers in another window
Journal Articles

Tamoxifen and Metabolite Concentrations in Serum and Breast Cancer Tissue during Three Dose Regimens in a Randomized Preoperative Trial

Elton R. Kisanga, Jennifer Gjerde, Aliana Guerrieri-Gonzaga, Francesca Pigatto, Adriana Pesci-Feltri, Chris Robertson, Davide Serrano, Giuseppe Pelosi, Andrea Decensi, Ernst A. Lien
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (7): 2336–2343.
https://doi.org/10.1158/1078-0432.CCR-03-0538
Published: 08 April 2004
View article titled, Tamoxifen and Metabolite Concentrations in Serum and Breast Cancer Tissue during Three Dose Regimens in a Randomized Preoperative Trial
Open the PDF for Tamoxifen and Metabolite Concentrations in Serum and Breast Cancer Tissue during Three Dose Regimens in a Randomized Preoperative Trial in another window
Journal Articles

Relationships between Plasma Insulin-like Growth Factor-I and Insulin-like Growth Factor Binding Protein-3 and Second Breast Cancer Risk in a Prevention Trial of Fenretinide

Andrea Decensi, Umberto Veronesi, Rosalba Miceli, Harriet Johansson, Luigi Mariani, Tiziana Camerini, Maria Gaetana Di Mauro, Elena Cavadini, Giuseppe De Palo, Alberto Costa, Marjorie Perloff, Winfred F. Malone, Franca Formelli
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (13): 4722–4729.
Published: 27 October 2003
View article titled, Relationships between Plasma Insulin-like Growth Factor-I and Insulin-like Growth Factor Binding Protein-3 and Second Breast Cancer Risk in a Prevention Trial of Fenretinide
Open the PDF for Relationships between Plasma Insulin-like Growth Factor-I and Insulin-like Growth Factor Binding Protein-3 and Second Breast Cancer Risk in a Prevention Trial of Fenretinide in another window
Journal Articles

Phase I Trial and Pharmacokinetics of Fenretinide in Children with Neuroblastoma

Alberto Garaventa, Roberto Luksch, Maria Serena Lo Piccolo, Elena Cavadini, Paolo G. Montaldo, Maria Rosa Pizzitola, Luca Boni, Mirco Ponzoni, Andrea Decensi, Bruno De Bernardi, Franca Fossati Bellani, Franca Formelli
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (6): 2032–2039.
Published: 01 June 2003
View article titled, Phase I Trial and Pharmacokinetics of Fenretinide in Children with Neuroblastoma
Open the PDF for Phase I Trial and Pharmacokinetics of Fenretinide in Children with Neuroblastoma in another window